News

A daily routine for children with type 1 diabetes: monitoring blood glucose.

Research fully realizes its value where it reaches people – when findings translate into new treatment options from which those affected can benefit. How this can be achieved in practice for type 1 diabetes is demonstrated by the Institute of…

Arzt mit Stethoskop und geöffneten Händen. Über den Händen schwebt eine schematische Grafik der Lunge. Daneben verschiedene Icons zu medizinischen Leistungen

Helmholtz Munich and Khumbu are collaborating on a new research program led by Prof. Ali Önder Yildirim, Director of the Institute of Lung Health and Immunity at Helmholtz Munich. The collaboration aims to develop a novel therapeutic approach for…

A new interdisciplinary team at Helmholtz Munich aims to bridge one of healthcare AI's longstanding challenges: translating promising algorithms into tools that perform reliably in clinical practice. The M1 Clinical AI Consultants, based at the…

Using advanced intravital microscopy, Helmholtz Munich researchers have been able to observe early immune reactions in the living lung in real time. The images show that specific T cells are activated within hours after contact with components of…

Dr. Robert Frömel and Dr. Hossam Montaser have been awarded Marie Skłodowska Curie Postdoctoral Fellowships. Over a period of two years, the EU funded fellowships will support their independent research projects on gene regulation in brain…

Cover of the Pixi book from Carlsen, which describes type 1 diabetes.

The new Pixi Wissen book, “Finn and the Sleepover – Type 1 Diabetes at School”, demonstrates how research can be translated into practical resources for everyday life. Together with partners, Helmholtz Munich has developed a scientifically grounded,…

Dr. Michael Witting has been awarded the Metabolomics Society Medal 2026. The international scientific society recognizes his contributions to the advancement and application of metabolomics methodologies. The medal was presented during the opening…

Dr. Steffen Schneider of Helmholtz Munich and KI macht Schule gGmbH has been admitted as a new member of the Young Academy. Working at the interface of artificial intelligence, neuroscience, and statistical modelling, Schneider joins the Academy's…

News

News

From the Lab to the Patient: Four Clinical Trials on Type 1 Diabetes

Helmholtz Munich and Khumbu Start Joint Program on COPD

Helmholtz Munich Launches M1 Clinical AI Consultants to Bring AI Research to Patient Care

SARS-CoV-2: Real-time Imaging Reveals Unexpectedly Fast Immune Response in the Lung

Two MSCA Postdoctoral Fellowships Awarded to Researchers at Helmholtz Munich

Pixi Wissen Book: Type 1 Diabetes at School

People & Grants

Two MSCA Postdoctoral Fellowships Awarded to Researchers at Helmholtz Munich

Michael Witting Receives Metabolomics Society Medal 2026

Steffen Schneider Admitted to the Young Academy

Press Contact